Business Standard

Online gamers could help vaccinate billions

- RHIJU DAS & MARTIN SKLADANY 15 October

Q uickly vaccinatin­g billions of people around the globe against Covid-19 is going to be an endeavour like no other in human history. What could make it even more difficult is that some of the leading contenders — MRNA (1) vaccines — have a very short shelf life: They have to be stored and shipped at temperatur­es as low as minus 80 degrees Celsius (minus 112 degrees Fahrenheit).

The private sector, as well as the US military, is trying to figure out how to manage that feat. But there’s another possibilit­y — and it relies on thousands of people playing an online game.

A relatively new technology, MRNA vaccines are promising because they can be created and manufactur­ed quickly. Pfizer and Moderna’s vaccine candidates (two of the first three to begin Phase 3 clinical trials in the US) are MRNA vaccines. Once thawed, however, an MRNA vaccine has to be used immediatel­y. Without a breakthrou­gh, such vaccines wouldn’t be widely available as the flu shot is. They probably would never reach developing countries.

But it should be possible to create a longer-lasting vaccine by redesignin­g a bit of its genetic code that, once injected into our bodies, instructs cells to create a protein that is identical to one on the exterior of the SARSCOV-2 virus. Just like a traditiona­l vaccine made from weakened or dead viral material, this protein teaches the immune system to recognise and destroy the virus that causes Covid-19.

Scientists can quite easily design an MRNA that codes for this protein. In fact, there is an astronomic­al number of possible MRNAS that will work. But the vast majority of those MRNA molecules are floppy

— and bits of a floppy MRNA molecule occasional­ly contort into folds that cause it to lose potency. The trick is finding an MRNA that still codes for the right protein but folds up into some stable three-dimensiona­l structure that can’t undergo such contortion­s. In other words, an MRNA built to stay effective for a long time in a regular refrigerat­or.

This biochemica­l problem is currently being worked on by thousands of people around the world — by playing a game called Eterna. Solving puzzles requires folding an RNA molecule into a particular shape by bonding base pairs of nucleotide­s. (RNA is made of four kinds of nucleotide­s.) It’s a simple point-and-click interface backed by state-of-the-art folding simulation­s. In recent years, the citizen science of Eterna has uncovered RNA design rules that can be used in emerging methods of disease detection and gene therapy. Most relevant for stabilisin­g current vaccines, Eterna has revealed rules for designing RNA molecules into unusually stable structures.

And once an MRNA vaccine is approved by the FDA, the work that Eterna is doing would allow the vaccine to be quickly redesigned in this new, stable shape. For example, several candidate vaccines encode for the SARS-COV-2 “spike” protein, so the stable MRNA shapes that Eterna is making should work for any of those. The clinical trials for such remodelled MRNA vaccines, because they’d build on previous trials, would be much faster, too.

So why tackle this scientific inquiry with a game? It turns out that big groups of humans are better — significan­tly so — at coming up with brand-new RNA structures than even the latest kinds of artificial intelligen­ce. No one knows exactly why this is. It seems to be, in part, because AI has baseline parameters set by only a few humans, while the game leverages the knowledge of thousands — programmer­s and plumbers, architects and astrophysi­cists, gamers and grandparen­ts.

These diverse individual­s take on weekly Eterna challenges that are created in a collaborat­ion between Stanford scientists and dozens of committed players. Given the vast structural possibilit­ies, players routinely generate RNA molecules that look like flowers, beaded necklaces, antlers, and other shapes never seen before by RNA researcher­s.

In recent years, Eterna has found that roughly 1 in 1,000 players has an aptitude for RNA problems that is as good as or better than that of top scientists. But all players are critical to the function of citizensci­ence games. It’s often the new players who hit upon a revolution­ary RNA structures — in part because they are unconstrai­ned by the norms of biochemist­ry.

AI has baseline parameters set by only a few humans, while the game leverages the knowledge of thousands

 ??  ??

Newspapers in English

Newspapers from India